FDA 483 - Maquet SAS - February 01, 2018

An FDA inspection of Maquet SAS, a medical device manufacturer in Orleans, France, revealed significant deficiencies in their quality management system. Observations included inadequate procedures for corrective and preventive actions, insufficient controls for incoming product acceptance, and a lack of proper validation for a final product testing process. These issues indicate a need for comprehensive improvements in their quality processes.